@prefix this: . @prefix sub: . @prefix np: . @prefix pav: . @prefix rdf: . @prefix infores: . @prefix xsd: . @prefix orcid: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "Prednisolone"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "tuberculous meningitis"; biolink:category biolink:DiseaseOrPhenotypicFeature . sub:_1 rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_2 rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_3 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_4 rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-11T07:41:33.845315"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627; prov:wasQuotedFrom " Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis. The drug is currently being used in the United States as well as Europe and Australia. It is available in Europe and Canada." . biolink: pav:version "2.3.0" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB"; npx:hasSignature "iK8+l4PT9DPYf/TtI/3+sMcq+AZn/PC2ydIh3HbhHs6gv+XgU+xMwUKbcM1OKuELL4nCsRVOpM2MHQ6vpwh9BmJTsu1/KtB7+GdBLv7K4Z/x3xqOr3zT7iXmsTR3JwLHJEkgs/PAtDcsESumJ/bCpnsLen9zPSPwlri6C2l+dyVY4By9QLFQU+PkAInS2dHVjQ0CrKgjeeCSCXhGGrfKbE1Htr8i2bMCQeF6RgTA4esWVvyfrHWch/Gsy6S7SwG8sbJ/hHQ/05gtKmfUvoiBOg25BgpdaF3nXV6a1MWb3ekTEV6cnbyq4fgEfMFfsQI9NV0ElY1z/Bd87lQ7SSZO8Q=="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-11T07:41:33.845315"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627 . }